Condition
Sarcoma Metastatic clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Sarcoma Metastatic clinical trials that are recruiting, at sites in 3 countries (most in United States (3), China (1), France (1)). By phase: Phase 2 (2), Early Phase 1 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 3Countries
Newest Sarcoma Metastatic clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| TumorGlow use during surgery to see sarcoma lung metastases in children | Early Phase 1 | Phildelphia, Pennsylvania | Recruiting | Jun 22, 2026 |
| Metformin plus standard first-line therapy for advanced soft tissue sarcoma | Phase 2 | Charlotte, North Carolina and 1 other locations | Recruiting | Dec 18, 2025 |
| Sequential CD146- and HER2-targeted CAR T-cell therapy for advanced sarcoma | Phase 1/2 | Beijing, Beijing Municipality | Recruiting | Jul 15, 2025 |
| Zanzalintinib treatment for advanced leiomyosarcoma | Phase 2 | Chicago, Illinois | Recruiting | Aug 26, 2024 |
| Evaluating a digital care plan for patients with advanced sarcomas on second-line treatment | — | Lyon, Auvergne-Rhône-Alpes and 10 other locations | Recruiting | Jan 18, 2024 |
All recruiting trials (5)
-
TumorGlow use during surgery to see sarcoma lung metastases in children
This pediatric study tests a single 5 mg/kg dose of TumorGlow (ICG) given before surgery to help doctors see sarcoma metastases in the lungs during tumor removal.
-
Metformin plus standard first-line therapy for advanced soft tissue sarcoma
This trial tests whether adding metformin to standard first-line systemic treatment helps people with previously untreated advanced or metastatic soft tissue sarcoma.
-
Sequential CD146- and HER2-targeted CAR T-cell therapy for advanced sarcoma
This treatment will test whether giving a patient's own CAR T cells that target CD146 and HER2, one after the other, can shrink tumors in children and adults with relapsed or refractory advanced sarcoma.
-
Zanzalintinib treatment for advanced leiomyosarcoma
This study is testing if a new medication called zanzalintinib can help people with advanced leiomyosarcoma live longer without their cancer getting worse.
-
Evaluating a digital care plan for patients with advanced sarcomas on second-line treatment
This study is testing if a new digital care plan can help people with advanced sarcomas on second-line treatment have fewer severe side effects compared to the usual care they receive.
Related topics
Quick answers
How many Sarcoma Metastatic clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (3 trials), China (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Early Phase 1: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.